Next Article in Journal
Strategies to Achieve Breast Health Equity in the St. Louis Region and Beyond over 15+ Years
Next Article in Special Issue
Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer
Previous Article in Journal
Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors
Previous Article in Special Issue
Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
 
 
Article

Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma

by 1,†, 2,3,†, 2, 2,3 and 2,3,4,5,6,7,8,9,10,*
1
Department of Accounting Information, Chihlee University of Technology, Taipei 22050, Taiwan
2
Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei 24205, Taiwan
3
Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei 24205, Taiwan
4
Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
5
Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 265501, Taiwan
6
Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 265501, Taiwan
7
Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan
8
Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 265501, Taiwan
9
Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei 110301, Taiwan
10
Department of Management, College of Management, Fo Guang University, Yilan 26247, Taiwan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Domenico Galetta
Cancers 2022, 14(10), 2553; https://doi.org/10.3390/cancers14102553
Received: 2 May 2022 / Revised: 17 May 2022 / Accepted: 21 May 2022 / Published: 22 May 2022
(This article belongs to the Special Issue Advances in Lung Cancer Therapy)
The survival impact of diabetes severity on lung cancer survival remains unclear. We performed head-to-head propensity score matching to estimate the survival impact of various adapted diabetes complications severity index (aDCSI) scores in patients with both diabetes and lung squamous cell carcinoma (SqCLC). The results indicated that diabetes severity (aDCSI ≥ 2) is an independent prognostic factor for the overall survival of patients with both diabetes and lung SqCLC who receive standard treatments. Prevention of diabetes progression is necessary for patients with diabetes; it affects not only diabetes control but also improves survival for patients with lung SqCLC.
Purpose: The survival impact of diabetes severity on lung cancer remains unclear. We performed head-to-head propensity score matching to estimate the survival impact of various adapted diabetes complications severity index (aDCSI) scores in patients with both diabetes and lung squamous cell carcinoma (SqCLC). Patients and Methods: We enrolled patients with both diabetes and lung SqCLC and categorized them into the mild (aDCSI = 0–1) and moderate-to-severe (aDCSI ≥ 2) diabetes groups. The patients in both groups were matched at a 1:1 ratio. Results: the matching process yielded a final cohort of 5742 patients with both diabetes and lung SqCLC (2871 patients in the mild diabetes group and 2871 patients in the moderate-to-severe diabetes groups) who were eligible for further analysis. A multivariate Cox regression analysis revealed that the adjusted hazard ratio (aHR; 95% confidence interval) of all-cause death for the mild diabetes group relative to the moderate-to-severe diabetes group was 1.17 (1.08–1.28; p = 0.0005). Conclusion: severe diabetes (aDCSI ≥ 2) is an independent prognostic factor for OS among patients with both diabetes and lung SqCLC who receive standard treatments. Preventing diabetes progression is necessary for patients with diabetes because it not only supports diabetes control but also improves survival for patients with lung SqCLC. View Full-Text
Keywords: severity of diabetes; lung cancer; survival; squamous cell carcinoma; propensity scores matching severity of diabetes; lung cancer; survival; squamous cell carcinoma; propensity scores matching
Show Figures

Figure 1

MDPI and ACS Style

Su, C.-H.; Chen, W.-M.; Chen, M.; Shia, B.-C.; Wu, S.-Y. Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma. Cancers 2022, 14, 2553. https://doi.org/10.3390/cancers14102553

AMA Style

Su C-H, Chen W-M, Chen M, Shia B-C, Wu S-Y. Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma. Cancers. 2022; 14(10):2553. https://doi.org/10.3390/cancers14102553

Chicago/Turabian Style

Su, Chih-Hsiung, Wan-Ming Chen, Mingchih Chen, Ben-Chang Shia, and Szu-Yuan Wu. 2022. "Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma" Cancers 14, no. 10: 2553. https://doi.org/10.3390/cancers14102553

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop